TransMedics Group's EBIT per Share for the
three
months ended in Mar. 2024 was $0.46.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.02.
During the past 3 years, the average EBIT per Share Growth Rate was 6.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 7.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for TransMedics Group's EBIT per Share or its related term are showing as below:
TMDX'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -10.8 Med: 6.1 Max: 20.1
Current: 6.1
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of TransMedics Group was 20.10% per year. The lowest was -10.80% per year. And the median was 6.10% per year.
TMDX's 3-Year EBIT Growth Rate is ranked better than 50.62% of 727
companies
in the Medical Devices & Instruments industry
Industry Median: 5.9
vs TMDX: 6.10
The historical data trend for TransMedics Group's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TransMedics Group (NAS:TMDX) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
TransMedics Group EBIT per Share Related Terms
Thank you for viewing the detailed overview of TransMedics Group's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
TransMedics Group (TransMedics Group) Business Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TMDX has been successfully added to your 